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ABSTRACT
In the present cross-sectional study of 403 independently living
elderly men, we tested the hypothesis that the decreases in bone mass,
body composition, and muscle strength with age are related to the fall
in circulating endogenous testosterone (T) and estrogen concentra-
tions. We compared various measures of the level of bioactive andro-
gen and estrogen to which tissues are exposed.
After exclusion of subjects with severe mobility problems and signs
of dementia, 403 healthy men (age, 73–94 yr) were randomly selected
from a population-based sample. Total T (TT), free T (FT), estrone
(E1), estradiol (E2), and sex hormone-binding globulin (SHBG) were
determined by RIA. Levels of non-SHBG-bound T (non-SHBG-T), FT
(calc-FT), the TT/SHBG ratio, non-SHBG-bound E2, and free E2 were
calculated. Physical characteristics of aging included muscle strength
measured using dynamometry, total body bone mineral density
(BMD), hip BMD, and body composition, including lean mass and fat
mass, measured by dual-energy x-ray absorptiometry.
In this population of healthy elderly men, calc-FT, non-SHBG-T,
E1, and E2 (total, free, and non-SHBG bound) decreased significantly
with age. T (total and non-SHBG-T) was positively related with mus-
cle strength and total body BMD (for non-SHBG-T, respectively, b 5
1.93 6 0.52, P , 0.001 and b 5 0.011 6 0.002, P , 0.001). An inverse
association existed between T and fat mass (b 5 20.53 6 0.15, P ,
0.001). Non-SHBG-T and calc-FT were more strongly related to mus-
cle strength, BMD, and fat mass than TT and were also significantly
related to hip BMD. E1 and E2 were both positively, independently
associated with BMD (for E2, b 5 0.21 6 0.08, P , 0.01). Non-SHBG-
bound E2 was slightly strongly related to BMD than total E2. The
positive relation between T and BMD was independent of E2. E1 and
E2 were not related with muscle strength or body composition.
In summary, bioavailable T, E1, total E2, and bioavailable E2 all
decrease with age in healthy old men. In this cross-sectional study in
healthy elderly men, non-SHBG-bound T seems to be the best pa-
rameter for serum levels of bioactive T, which seems to play a direct
role in the various physiological changes that occur during aging. A
positive relation with muscle strength and BMD and a negative re-
lation with fat mass was found. In addition, both serum E1 and E2
seem to play a role in the age-related bone loss in elderly men, al-
though the cross-sectional nature of the study precludes a definitive
conclusion. Non-SHBG-bound E2 seems to be the best parameter of
serum bioactive E2 in describing its positive relation with BMD.
(J Clin Endocrinol Metab 85: 3276–3282, 2000)
THROUGHOUT ADULT life, all physiological functionsgradually decline. In men, part of these age-related
physiological changes (loss of muscle size and strength, loss
of bone, and increase in fat mass) may be related to the
decrease in serum levels in bioavailable testosterone (T) with
aging (1, 2). Some studies report a positive relation between
estimates of serum T levels and bone density in older men (1,
3, 4), although this has not been a universal finding (5, 6).
Androgen administration to older men with low plasma T
levels results in increases in lean body mass, bone density,
and/or muscle strength (7–10).
Recently it has been suggested that estrogens may play an
important role in the development and maintenance of the male
skeleton (11). Several studies have reported positive relations
between serum estradiol (E2) concentrations and bone mineral
density (BMD) or bone turnover markers in men (12).
Serum T as well as E2 are mainly bound to sex-hormone
binding globulin (SHBG) and albumin. It has been suggested
that the fraction of T bound to albumin has access to target
tissues (13). It remains to be established whether total, non-
SHBG-bound (albumin bound and free) or free T (FT) levels
are the best representation of the bioactive hormone con-
centrations. The same holds true for serum E2 concentrations.
Therefore, in the present cross-sectional study of 403 inde-
pendently living elderly men, we tested the hypothesis that the
decreases in bone mass, body composition, and muscle strength
with age are related to the fall in circulating endogenous T and
estrogen concentrations. We compared various measures of the
level of bioactive androgen to which tissues are exposed: total
T (TT) and FT levels in serum, the TT/SHBG ratio, calculated
free and non-SHBG-bound T levels and TT adjusted for SHBG.
In addition, relationships with total, non-SHBG-bound, and
free estradiol (fE2) were compared.
Subjects and Methods
Subjects
The study is a cross-sectional, single-center study in 403 indepen-
dently living men, 70 yr of age and higher. Names and addresses of all
male inhabitants 70 yr and older were drawn from the municipal register
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of Zoetermeer, a medium sized town in the midwestern part of The
Netherlands. A total of 1567 men were invited, and after exclusion of
subjects who did not live independently and subjects who were not
physically or mentally able to visit the study center independently,
eventually 403 men participated (25.7%). A total of 886 men did not
respond to the mailed invitation in which it was already mentioned that
subjects who did not live independently or with severe mobility prob-
lems would not be allowed to participate. The main reason not to
participate among the respondents was because they were already being
seen by a specialist or general practitioner at the moment (28%), whereas
16% were excluded on the basis of physical (10%) or mental (6%) prob-
lems. Participants signed an informed consent. The study has been
approved by the Medical Ethics Committee of the Erasmus University
Hospital Rotterdam. No additional health-related eligibility criteria
were used. A number of participants were taking medications for
chronic illnesses, like hypertension (n 5 96) and mild congestive heart
failure (n 5 28). However, none of these medications, in retrospect,
influenced the relations described in this study. Some of the illnesses, for
example mild knee pain (n 5 79), influenced the physical characteristics
measured, but, in retrospect, they did not change the relations between
the physical characteristics nor between the circulating hormone levels
and the physical characteristics reported in this study.
Hormone measurements
Blood samples were collected in the morning after an overnight fast.
The period of storage at 240C varied from 0–5 months. Serum concen-
trations of TT (nmol/L), FT (nmol/L), and SHBG (nmol/L) were all
measured by RIA using commercial kits (Diagnostic Systems Labora-
tories, Webster, TX). The intra assay coefficients of variation (CV) for
these assays were 8.1%, 6.2%, and 3.0%, respectively. The interassay CV
were 10.5%, 9.7%, and 4.4%. The FT RIA uses an [I-125]-labeled T analog,
which has a low affinity for SHBG and albumin. This analog competes
with the unbound T in the test sample for binding to specific anti-T
polyclonal antibodies that have been immobilized on the assay tube.
This competitive binding format allows direct estimation of unlabeled
FT levels in unextracted samples. Furthermore, as measures of biolog-
ically active T, the TT/SHBG ratios were calculated, as well as FT
(calc-FT, nmol/L) and non-SHBG-bound T (non-SHBG-T, nmol/L, is
calc-FT plus albumin-bound T) (Table 1) (14). In these calculations, the
possible binding of other steroids to SHBG was disregarded. Finally, TT
adjusted for SHBG in a multiple regression analysis was used as a
measure of non-SHBG-bound T.
Serum concentrations of estrone (E1; nmol/L) and E2 (nmol/L) were
also measured by RIA using commercial kits (Diagnostic Systems Lab-
oratories). The intra-assay CV were, respectively, 5.6% and 5.3%. The
interassay CV were, respectively, 10.2% and 8.1%. As measures of bi-
ologically active E2, fE2, and non-SHBG-bound E2 were calculated ac-
cording to the method described by So¨dergård et al. (14), taking the
concentration of T into account. Albumin (g/L) was measured by pho-
tometry using a commercial kit (ALB; Boehringer, Mannheim,
Germany).
Physical characteristics of aging
Muscle strength. Isometric grip strength (IGS) was measured using an
adjustable hand held dynamometer (JAMAR dynamometer) at the non-
dominant hand (15). Each test was repeated three times, and the average
was used in the analyses. Leg or knee extensor strength (LES) was
measured as described previously (16, 17), using the Hoggan MicroFET
hand-held dynamometer. To obtain one main outcome measurement for
LES, “maximum LES” (maxLES) was defined as the maximum strength
for the right or left leg, whichever is largest, in a position of 120-degree
extension. Statistical analyses were based on the physical unit momen-
tum (Nm), obtained by multiplying the maximum strength (in Newton)
and the distance of the dynamometer to the knee joint (in meters).
BMD and body composition
Total body BMD (TBBMD) was measured using dual-energy x-ray ab-
sorptiometry (Lunar, Madison, WI), as were hip BMDs at the femoral neck,
trochanter, and Ward’s triangle (18). In addition, total and trunk lean body
mass and fat mass were measured (19, 20). Quality assurance for dual-
energy x-ray absorptiometry, including calibration, was performed every
morning, using the standard provided by the manufacturer.
Height and weight were measured in standing position without
shoes. Body mass index (BMI) was calculated as the weight in kilograms
divided by the square of the height in meters. The waist circumference
was measured at the level of the umbilicus, and the hip circumference
was measured at the level of the greater trochanter. The average of two
readings was used in the analyses. Waist to hip ratio, which represents
a measure of upper body adiposity, was calculated from these two
measurements.
Data analyses. Results were expressed, unless otherwise stated, as mean
and sd with the interquartile range. Comparisons between groups were
made by using Student’s t test. Differences were given together with the
95% confidence interval. Relations between variables were assessed
using linear regression for continuous variables and logistic regression
for binary variables and described as the linear regression coefficient (b)
and its se. Multiple regression analysis was used to adjust for age and
BMI, as well as to assess the contribution of different independent
variables to the dependent variable. To assess the contribution of dif-
ferent variables on the dependent parameter, we used standardized
regression, described as the standardized regression coefficient (B). Bs
are regression coefficients normalized by the ratio of the sd of the
dependent variable. Correlations between variables were assessed by
TABLE 1. Measurements and calculations for the various concentrations of T and E2
Steroid variables Measurements and calculations
TT (nmol/L) Measured by RIA (Diagnostic Systems Laboratories-4100, Webster, TX)
FT (nmol/L) Measured by RIA (Diagnostic Systems Laboratories-4900)
calc-FT (nmol/L) According to So¨degård et al. (14): calc-FT 5 [2b 1 =(b2 1 4a[STT])]/2a
a 5 KA 1 KT 1 (KA 3 KT) ([SHBG] 1 [albumin] 2 [STT])
b 5 1 1 KT[SHBG] 1 KA[albumin] 2 (KA 1 KT)[STT]
Non-SHBG-T (nmol/L) According to So¨degård et al. (14): non-SHBG-T 5 (KA 3 [albumin] 3 [calc-FT])/(1 1 KA 3 [calc-
FT]) 1 [calc-FT]
TT/SHBG ratio Measured TT/measured SHBG ratio
TT adjusted SHBG, nmol/L Measured TT
Adjusted for measured SHBG in a multiple regression analysis
E2 (nmol/L) Measured by RIA (Diagnostic Systems Laboratories-4400)
fE2 (nmol/L) According to So¨degård et al. (14): fE2 5 [2b 2 ~˛b224ac)]/2a
a 5 (KA 3 [albumin] 1 1)(KE)
b 5 ([SE2] 3 KE) 2 (KAE 3 [albumin] 1 1)(1 1 KT[SHBG] 3 calc-FT) 2 (KE 3 [SHBG])
c 5 [SE2] 3 (1 1 KT[SHBG] 3 calc-FT)
Non-SHBG-E2 (nmol/L) According to So¨degård et al. (14): non-SHBG-E2 5 [SE2] 2 (K
E 3 [SHBG] 3 fE2/(1 1 KE 3 fE2
1 KT[SHBG] 3 calc-FT)
KA, Association constant for binding of T to albumin; KT, association constant for binding of T to SHBG; KAE, association constant for binding
of E2 to albumin; K
E, association constant for binding of E2 to SHBG.
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using Pearson’s correlation coefficient r. All analyses were done using
STATA Statistical Software, Release 5.0 (Stata Corporation, Texas).
Results
Descriptive data of the physical characteristics, as well as
age and BMI are shown in Table 2. Muscle strength, BMD,
lean body mass, and fat mass all decreased with age in our
study group (Table 3). Because virtually all parameters were
related with age, all further analyses were done after adjust-
ment for age. Descriptive data of the hormone measurements
are shown in Table 4.
Relations of the hormone concentrations with age
The relations of the hormone measurements with age are
shown in Table 5. In our population, all T measurements,
except TT, significantly decreased with age. The relation
between non-SHBG-bound T and age is illustrated in Fig. 1.
Serum SHBG and percentages of SHBG-bound T and E2
increased with age. E1 and total E2 concentrations were in-
versely related with age. Calculated fE2 and calculated non-
SHBG-bound E2 (non-SHBG-E2) decreased relatively more
with age compared with total E2 (Bs were, respectively,
20.15, 20.15, and 20.12).
Relations between physical characteristics
Lean mass, fat mass, and maxLES were all positively,
independently related with TBBMD [respectively, b 5
0.0060 6 0.0008 kg/(g/cm2), P , 0.001; b 5 0.0063 6 0.0008
kg/(g/cm2), P , 0.001; and b 5 0.0011 6 0.0002 Nm/(g/
cm2), P , 0.001]. Lean mass and maxLES were both positively
associated (b 5 0.12 6 0.01 Nm/kg, P , 0.001).
Relations between hormone concentrations
Mean values of measured FT were significantly lower than
calc-FT (difference 0.16 6 0.003 nmol/L, confidence inter-
val 5 0.156–0.166, P , 0.001). Results of the different T
measurements correlated well with each other (Table 6). Cor-
relations between serum levels of T, E1, and E2 are shown in
Table 7. E1 and E2 were positively related with each other,
and with the various measures of T.
Relation between T concentrations and physical
characteristics
Because BMI was significantly related to levels of T, max-
LES, IGS, and BMD, all analyses including these parameters
were done after adjustment for BMI.
All T measurements were positively related to TBBMD
after adjustment for age (Table 8). Calc-FT, non-SHBG-T, the
TT/SHBG ratio, and TT adjusted for SHBG were also sig-
nificantly positively related to all regions of proximal femur
BMD. As an example, the relationships between the different
T measures and BMD of the Ward’s triangle are shown in
Table 8.
None of the T measurements, with the exception of the
TT/SHBG ratio, was related with lean mass (data not
shown). Fat mass was negatively associated with all T mea-
surements, except with the TT/SHBG ratio (Table 8).
All measurements for T were positively related with max-
LES (Table 8) and with IGS and after adjustment for age (with
the exception that FT was not related with IGS). T was in-
dependently related to both muscle strength and BMD.
The SHBG-bound fraction of T was not related to any of
the physical characteristics, with the exception of fat mass
(b 5 21.03 6 0.18, P , 0.001). The strength of the relations
of the albumin-bound fraction of T to the physical charac-
teristics was equal to those for non-SHBG-T.
Serum SHBG concentrations were inversely related to lean
mass [b 5 20.07 6 0.02 kg/(nmol/L), P , 0.001], fat mass
[b 5 20.08 6 0.02 kg/(nmol/L), P , 0.001], and BMD [e.g.
TBBMD; b 5 20.001 6 0.0003 (g/cm2)/(nmol/L), P 5 0.01].
Relations between estrogens and physical characteristics
Serum E1 and E2 concentrations were not related to muscle
strength. In this elderly male population, serum E1 levels
TABLE 2. Descriptive data of the study population
Mean 6SD Interquartilerange
Age (yr) 77.8 3.58 75 80
BMI 25.5 3.0 23.3 27.3
IGS (kg) 34.3 6.9 30.0 38.7
maxLES (Nm) 103.2 20.9 89.43 117.12
Total fat mass (kg) 21.2 6.4 17.4 24.5
Trunk fat mass (kg) 10.6 2.6 9.0 12.4
Total lean mass (kg) 51.7 5.6 47.8 55.5
TBBMD (g/cm2) 1.17 0.10 1.11 1.23
Femoral neck BMD (g/cm2) 0.88 0.14 0.78 0.97
Femoral ward BMD (g/cm2) 0.72 0.16 0.60 0.82
Femoral trochanter BMD (g/cm2) 0.85 0.15 0.76 0.94
TABLE 3. Relationship between physical characteristics and age
Age (yr)
b 6SE P
IGS (kg) 20.53 0.09 ,0.001
maxLES (Nm) 21.30 0.28 ,0.001
Total fat mass (kg) 20.18 0.08 0.02
Trunk fat mass (kg) 20.10 0.04 0.007
Total lean mass (kg) 20.38 0.08 ,0.001
TBBMD (g/cm2) 20.003 0.001 0.006
Femoral neck BMD (g/cm2) 20.002 0.002 0.25
Femoral ward BMD (g/cm2) 20.003 0.002 0.17
Femoral trochanter BMD (g/cm2) 20.004 0.002 0.04
TABLE 4. Summarized values of hormone levels in serum from
403 men with ages between 73 and 94 yr
Mean 6 SD Interquartilerange
TT (nmol/L) 8.83 2.98 7.19 10.66
FT (nmol/L) 0.03 0.01 0.024 0.038
SHBG (nmol/L) 31.5 14.4 23.18 37.46
Calculated FT (nmol/L) 0.19 0.06 0.16 0.23
Non-SHBG-T (nmol/L) 5.68 1.89 4.62 6.76
Percentage SHBG-bound T (%) 35.0 9.51 29.2 41.1
Percentage albumin-bound T (%) 62.8 9.23 56.9 68.6
Percentage free T (%) 2.21 0.31 2.03 2.39
TT/SHBG ratio 0.32 0.15 0.23 0.39
E1 (nmol/L) 0.102 0.039 0.075 0.126
E2 (nmol/L) 0.098 0.058 0.059 0.126
Calculated fE2 (pmol/L) 2.5 1.4 1.5 3.2
Non-SHBG-E2 (nmol/L) 0.077 0.045 0.045 0.100
Percentage SHBG-bound E2 (%) 21.9 7.40 17.2 26.1
Percentage albumin-bound E2 (%) 75.5 7.21 71.4 80.2
Percentage fE2 (%) 2.56 0.24 2.42 2.72
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were positively associated with TBBMD [b 5 0.36 6 0.12
(g/cm2)/(nmol/L), P 5 0.004, age adjusted]. Serum E2 con-
centrations (total, free, and non-SHBG bound) were posi-
tively related to TBBMD as well as to hip BMD (Table 9).
Serum E1 contributed slightly more to the variation in
TBBMD, as shown by the Bs (respectively, 0.10 for E2 and 0.13
for E1). To investigate whether the above described effect of
T on BMD might be mediated through its aromatization to
estrogens, a multiple regression analysis was performed,
including BMD as the dependent variable and E2 and T as the
independent variables. E2 and TT remained independently
related to TBBMD and contributed equally to the variation
of TBBMD, as shown by the Bs (both 0.11). Again, serum E1
contributed to a slightly greater variation in TBBMD com-
pared with TT (Bs, respectively, 0.12 and 0.10). Furthermore,
with regard to hip BMD, E2 and non-SHBG-T remained in-
dependently, significantly related to BMD. Similar results
were obtained when non-SHBG-E2 was the independent
variable.
Measures of E1 and E2 were not related to body compo-
sition nor to lean mass, total or trunk fat mass. Nor were they
related to fat mass after adjustment for T. A weak positive
association was found between E1 and waist to hip ratio [b 5
0.13 6 0.07/(nmol/L), P 5 0.05].
Discussion
In this population, circulating non-SHBG-bound T and FT,
E1, and E2 (total, free, and non-SHBG-bound) levels all de-
clined with age. Serum TT did not change with age, whereas
the SHBG-bound fraction of both T and E2 increased with
age. Serum concentrations of the non-SHBG-T were most
strongly related to several physical characteristics of aging;
positively with muscle strength and BMD, and inversely
with fat mass. Serum E1 and E2 concentrations were posi-
tively associated with BMD, but not with muscle strength.
Free and non-SHBG-bound E2 were more strongly related to
BMD than total E2.
Serum T concentrations as found in this study seem to be
relatively low. Furthermore, calc-FT concentrations were sig-
nificantly higher than measured FT. It has to be questioned
whether the FT assay provides a good method to measure the
biologically active fraction of circulating T. Our findings that
FT (both measured and calculated), non-SHBG-T, and the
TT/SHBG ratio decrease with increasing age are in agree-
ment with previous studies (2, 21, 22). TT levels did not
decrease with age, but TT levels in this population were
below the normal range for middle-aged adults, suggesting
that T levels had already declined in comparison with
younger men. To our knowledge, no reference values for
percentage of SHBG bound, albumin bound and free frac-
tions of T exist in the elderly. The decrease of bioavailable T
is probably due to the increase of SHBG-bound T with age,
in combination with the decrease of the albumin-bound frac-
tion to a similar extent.
Until recently, not much attention has been paid to the role
of estrogens in elderly men. The studies that have been reported
so far show no change of total E2 levels with age in men (23–25)
or a decrease of E2 levels only at old age (26). In the present
study, serum total E2 was inversely associated with age. Bio-
available and fE2 concentrations decreased with age to an even
greater extent than total E2. Two earlier studies also reported a
decrease of bioavailable E2 (12, 25). We studied, however, an
older and larger population compared with these studies. As
with T, the SHBG-bound fraction of serum E2 increased with
age, whereas the albumin fraction decreased. In addition, se-
rum E1 concentrations decreased with age.
A number of clinical problems prevalent in older men may
be related to androgen deficiency, including reduced muscle
strength (27, 28), changes in body composition, and loss of
BMD (1, 3, 4). It should be of interest to know whether the
decrease in bone mass with age is causally related with the
decrease in lean mass and/or in serum T or E2 concentra-
tions. Also, it would be important to investigate whether the
fall in lean mass with age is caused by the decrease in muscle
strength and/or serum T or E2 concentrations. Finally, also
the reverse could be the case, in which the decrease in muscle
strength with age is caused by the fall in lean mass, and/or
serum T levels or other factors. Unfortunately, the cross-
sectional nature of our study does not allow a differentiation
between cause and effect. All the factors are statistically
related, making it impossible to differentiate which factor
explains another. Therefore, no conclusions can be drawn
FIG. 1. Relationship between non-SHBG-bound T and age. Coeffi-
cient denotes the linear regression coefficient. F.e. non-SHBG-bound
T decreases 0.07 nmol/L per year.
TABLE 5. Relationship between age and hormone levels
Age (yr)
b 6SE P
TT (nmol/L) 20.04 0.04 0.37
FT (nmol/L) 20.001 0.0001 ,0.001
SHBG (nmol/L) 0.92 0.20 ,0.001
Calculated FT (nmol/L) 20.002 0.001 0.02
Non-SHBG-T (nmol/L) 20.07 0.03 0.01
Percentage SHBG-bound T (%) 0.66 0.13 ,0.001
Percentage albumin-bound T (%) 20.64 0.12 ,0.001
Percentage fT (%) 20.029 0.004 ,0.001
TT/SHBG ratio 20.009 0.002 ,0.001
E1 (nmol/L) 20.005 0.0005 ,0.001
E2 (nmol/L) 20.002 0.0008 0.01
Calculated fE2 (pmol/L) 20.060 0.020 0.003
Non-SHBG-E2 (nmol/L) 20.002 0.001 0.002
Percentage SHBG-bound E2 (%) 0.51 0.10 ,0.001
Percentage albumin-bound E2 (%) 20.50 0.10 ,0.001
Percentage fE2 (%) 20.013 0.003 ,0.001
b, Coefficient of linear regression represents changes in unit per
year (e.g. non-SHBG-T decreases 0.07 nmol/L per year).
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concerning the physiological pathway(s). For example, also
physical activity per se might be a factor contributing to the
relationships found. A longitudinal study is necessary to
answer these questions. From the results of our study, we
can, however, confirm previous findings that serum T was,
independent of age, positively related to both IGS and max-
LES. In addition, we found a positive, age-independent re-
lation between estimates of serum T levels and bone density.
Furthermore, in agreement with previous findings, T was
inversely associated with fat mass, but not with lean body
mass (1). Serum non-SHBG-bound T concentrations are not
only related to TBBMD, but also to all regions of the proximal
femur BMD.
In this study, we established whether free T, the non-
SHBG-bound fraction of T, or TT measured in plasma rep-
resent the bioactive hormone best. Pardridge (13) suggested
that albumin-bound T is available for uptake by most tissues,
whereas SHBG-bound T is not. Considering the fact that
non-SHBG-T as well as the albumin-bound fraction were
strongly related to the physical characteristics of aging, it is
possible that the albumin-bound fraction of T is available for
uptake by tissues and can exert biological effects. Further-
more, in agreement with the suggestion of Pardridge (13),
SHBG-bound T was not related to any physical characteristic.
Serum non-SHBG-T concentrations were stronger related to
the physical characteristics than TT, as shown by the Bs, and
slightly stronger than serum calc-FT concentrations. In ad-
dition, non-SHBG-T levels were related to proximal femur
BMD, whereas TT levels were not.
There was a considerable difference in the relationships
TABLE 6. Age-adjusted relations between different measures of T concentrations
TT (nmol/L) TT/SHBG ratio Calc-FT (nmol/L)
b 6 SE r b 6 SE r b 6 SE r
Measured FT (nmol/L) 181.1 6 7.19 0.78a 0.03 6 0.004 0.39a 0.15 6 0.007 0.75a
Calculated FT (nmol/L) 42.80 6 1.00 0.91a 0.29 6 0.02 0.68a
Non-SHBG-T (nmol/L) 1.42 6 0.04 0.89a 8.98 6 0.45 0.71a
TT/SHBG ratio 8.04 6 0.92 0.40a
a P , 0.001.
TABLE 7. Age-adjusted relations between serum T and estrogens levels
TT (r) Non-SHBG-T (r) calc-FT (r) E1 (r) E2 (r) fE2 (r)
E1 0.28
a 0.28a 0.29a
E2 0.17
a 0.18a 0.14b 0.24a
fE2 0.14
b 0.20a 0.16b 0.24a 0.98a
Non-SHBG-E2 0.13
b 0.20a 0.18a 0.24a 0.99a 0.995a
a P , 0.001.
b P , 0.01.
TABLE 8. Relations between T measurements and physical characteristics of successful aging
maxLES (Nm) TBBMD (g/cm2) Ward BMD (g/cm2) Fat mass (kg)
b SE B b SE B b SE B b SE B
TT (nmol/L) 0.99 0.33 0.14a 0.004 0.001 0.13a 0.005 0.003 0.08b 20.49 0.09 20.13c
FT (nmol/L) 151.1 76.6 0.10d 0.69 0.35 0.09d 0.88 0.63 0.07b 286.0 21.8 20.10c
Calculated FT (nmol/L) 55.5 15.4 0.17c 0.28 0.07 0.18c 0.35 0.13 0.14a 216.6 4.5 20.13c
Non-SHBG-T (nmol/L) 1.93 0.52 0.17c 0.011 0.002 0.20c 0.012 0.004 0.14a 20.53 0.15 20.13c
TT/SHBG ratio 25.5 6.56 0.18c 0.14 0.03 0.22c 0.14 0.05 0.13a 21.77 1.93 20.12b
TT adjusted for SHBG (nmol/L) 1.11 0.34 0.16c 0.005 0.002 0.16c 0.007 0.003 0.12d 20.42 0.10 20.14c
b, coefficient of linear regression; B, standardized linear regression coefficient.
All analyses were done after adjustment for age and BMI.
a P # 0.01.
b P . 0.05.
c P # 0.001.
d P # 0.05.
TABLE 9. Relation between serum E2 concentrations and BMD
E2 (nmol/L) fE2 (pmol/L) Non-SHBG-E2 (nmol/L)
b 6 SE B b 6 SE B b 6 SE B
TBBMD (g/cm2) 0.21 6 0.08 0.13a 0.009 6 0.003 0.14a 0.31 6 0.10 0.14a
Femur neck BMD (g/cm2) 0.26 6 0.12 0.11b 0.011 6 0.005 0.11b 0.36 6 0.16 0.11b
Femur ward BMD (g/cm2) 0.29 6 0.14 0.11b 0.013 6 0.006 0.11b 0.42 6 0.18 0.12b
Femur trochanter BMD (g/cm2) 0.32 6 0.12 0.12a 0.013 6 0.005 0.13a 0.41 6 0.15 0.13a
b, Coefficient of linear regression; B, standardized linear regression coefficient.
All analyses were done after adjustment for age and BMI.
a P # 0.01.
b P # 0.05.
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between non-SHBG-bound T calculated according to the
method described by So¨dergård et al. (14), and the TT/SHBG
ratio as a measurement of non-SHBG-bound T, on the one
hand, and the physical characteristics, on the other hand. The
TT/SHBG ratio probably reflects in part the non-T-depen-
dent inverse association of SHBG with these characteristics
(demonstrated in the relation with lean mass, fat mass, and
BMD). Furthermore, use of the ratio obfuscates the absolute
levels of the components of the quotient. TT adjusted for
SHBG as a measure of non-SHBG-bound T is probably a
better parameter than TT/SHBG, because the inverse asso-
ciations of SHBG are not taken into account. However, as
judged by the Bs, it shows no clear advantage compared to
non-SHBG-T. Thus, the calculated bioavailable T concentra-
tion, according the method described by So¨dergård et al. (14),
seems to be an easy, inexpensive, and informative measure
in representing the bioactive fraction of circulating T.
Most of the E2 and about 20% of E1 produced in normal
men is formed by extraglandular aromatization of circu-
lating androgens. A smaller part of the circulating E2 is
derived from a direct secretion by the testicles (29). Most
of the E1 in elderly men is produced by the adrenals.
Recently it has been demonstrated that estrogens play an
important role in maintaining BMD in healthy older men
(5, 30). Trabecular bone is generally thought to be more
responsive to gonadal steroids than cortical bone. How-
ever, we did not measure spinal BMD, because degener-
ative arthritis influences the outcome of measurements too
strongly. In our population, serum total E2 was indepen-
dent of age, strongly positively related to BMD at all sites
measured. Serum non-SHBG-bound E2 was slightly stron-
ger related to BMD at all sites measured compared with
total E2, as shown by the Bs. This suggests that the non-
SHBG-bound fraction of E2 is the best representation of
bioactive hormone, although to a lesser extent than is the
case for T, possibly because E2 is more dissociable from
SHBG than T. These findings are in agreement with those
described by Khosla et al. (12). Also serum E1 concentra-
tions were related to bone density, although to TBBMD
only. However, this relation was independent of E2 and T
and contributed to an even greater extent to the variation
in TBBMD than E2 or T levels. This might imply that E1 has
an effect on BMD directly, or that it is locally converted to
E2. Serum T and E2 both contribute equally to the variation
in BMD, suggesting that the effect of T on bone is not only
attributed to the aromatization to estrogens (31).
Although it is generally accepted that estrogens and fat
mass, especially trunk fat, are strongly related in postmeno-
pausal women (32), we did not find a significant relation
between E1 or E2 and (trunk) fat mass in these elderly men,
before or after adjustment for T. This confirms other findings
that aromatase activity is also present in other tissues apart
from fat (33–36).
In summary, together with a decline in muscle strength,
bone density, and body composition, bioavailable T, E1, total
E2, and bioavailable E2 all decrease with age in healthy old
men. In this cross-sectional study in healthy elderly men,
non-SHBG-bound T seems to be the best parameter for serum
levels of bioactive T, which seems to play a direct role in the
various physiological changes that occur during aging
through its positive relation with muscle strength and BMD
and its negative relation with fat mass. In addition, both
serum estrone and estradiol seem to play a role in the age-
related bone loss in elderly men, although the cross-sectional
nature of this study precludes definitive conclusion. Non-
SHBG-bound E2 seems to be the best parameter for serum
levels of bioactive E2 in describing its positive relation with
BMD.
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